drugset / Trial / NCT01281488
Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors
RandomizedSingle-groupSingle-blindTreatment
Summary
RATIONALE: Using fluorescence imaging may determine the extent of kidney tumors and help in planning surgery. PURPOSE: This phase I trial is studying the best way to give indocyanine green (ICG) fluorescence imaging in finding tumors in patients with kidney tumors
Timeline
- Start
- 2011-10-20
- Primary completion
- 2017-10-09
- Completion
- 2017-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.018 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.036 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.07 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.14 mg/kg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.21 mg/kg | Intravenous |